# reload+after+2024-01-23 19:46:31.333169
address1§1305 O’Brien Drive
city§Menlo Park
state§CA
zip§94025
country§United States
phone§650 521 8000
website§https://www.pacb.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
fullTimeEmployees§769
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Christian O.  Henry M.B.A.', 'age': 55, 'title': 'President, CEO & Director', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 1098254, 'exercisedValue': 0, 'unexercisedValue': 1267134}, {'maxAge': 1, 'name': 'Ms. Susan G. Kim', 'age': 47, 'title': 'Chief Financial Officer', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 564873, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mark  Van Oene', 'age': 50, 'title': 'Chief Operating Officer', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 772112, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jeff  Eidel', 'age': 46, 'title': 'Chief Commercial Officer', 'yearBorn': 1977, 'fiscalYear': 2022, 'totalPay': 435618, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Stephen  Turner', 'age': 55, 'title': 'Co-Founder & CTO', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 341250, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Michele  Farmer CPA', 'age': 43, 'title': 'VP & Chief Accounting Officer', 'yearBorn': 1980, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jonas  Korlach Ph.D.', 'title': 'Chief Scientific Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Trevin  Rard', 'title': 'Head of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Brett  Atkins J.D., Ph.D.', 'title': 'General Counsel & Corporate Secretary', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Natalie  Welch', 'title': 'Chief People Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§6
boardRisk§3
compensationRisk§7
shareHolderRightsRisk§4
overallRisk§5
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.849
priceToSalesTrailing12Months§14.830215
currency§USD
dateShortInterest§1702598400
forwardEps§-0.99
pegRatio§7.67
exchange§NMS
quoteType§EQUITY
shortName§Pacific Biosciences of Californ
longName§Pacific Biosciences of California, Inc.
firstTradeDateEpochUtc§1288186200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§afbf9e1c-8320-3cad-8278-ee8ce023e356
gmtOffSetMilliseconds§-18000000
targetHighPrice§20.0
targetLowPrice§8.0
targetMeanPrice§12.68
targetMedianPrice§11.5
recommendationMean§2.2
recommendationKey§buy
numberOfAnalystOpinions§14
quickRatio§4.339
grossMargins§0.3114
ebitdaMargins§-1.7113
trailingPegRatio§None
